Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Fernandez

Showing results (211-220 of 270) with videos related to

Pageof 27
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 2, 2012
Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 genePablo Fernandez-Navarro, Guillermo Pita, Carmen Santamariña, et al.
Acta Neuropathologica|September 9, 2015
A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical diseasePriya Gami, Christina Murray, Lucia Schottlaender, et al.
BMC Medical Genetics|June 11, 2011
ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: a case control studyBerta Almoguera, Rosa Riveiro-Alvarez, Jorge Lopez-Castroman, et al.
BMC Medical Informatics and Decision Making|July 2, 2025
A systematic review of microsimulation models for skin cancerCaroline G Watts, Kirstie G McLoughlin, Stephen Wade, et al.
Plos One|December 26, 2025
A protocol for development of a microsimulation model platform to evaluate the potential benefits, harms, and cost-effectiveness of risk-tailored melanoma screeningKirstie G McLoughlin, Caroline G Watts, Stephen Wade, et al.
The Australasian Journal of Dermatology|February 21, 2022
Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanomaThomas E Pennington, Cathy Yunjia Zhao, Andrew J Colebatch, et al.
Organic & Biomolecular Chemistry|April 10, 2015
Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitorsMaria J Pineda de las Infantas, Sara Torres-Rusillo, Juan Diego Unciti-Broceta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 13, 2023
Contribution of <i>APOE</i> Genetic Variants to DyslipidemiaAna M Bea, Asier Larrea-Sebal, Victoria Marco-Benedi, et al.
Diabetes|June 30, 2022
Fibronectin-Integrin α5 Signaling in Vascular Complications of Type 1 DiabetesMinghao Chen, Rui Hu, Cristina Cavinato, et al.
JAMA Dermatology|March 17, 2021
Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin SurveillancePascale Guitera, Scott W Menzies, Elliot Coates, et al.
Pageof 27

Showing results (211-220 of 270) with videos related to

Sort By:
Pageof 27
European Journal of Cancer (Oxford, England : 1990)|October 2, 2012
Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 genePablo Fernandez-Navarro, Guillermo Pita, Carmen Santamariña, et al.
Acta Neuropathologica|September 9, 2015
A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical diseasePriya Gami, Christina Murray, Lucia Schottlaender, et al.
BMC Medical Genetics|June 11, 2011
ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: a case control studyBerta Almoguera, Rosa Riveiro-Alvarez, Jorge Lopez-Castroman, et al.
BMC Medical Informatics and Decision Making|July 2, 2025
A systematic review of microsimulation models for skin cancerCaroline G Watts, Kirstie G McLoughlin, Stephen Wade, et al.
Plos One|December 26, 2025
A protocol for development of a microsimulation model platform to evaluate the potential benefits, harms, and cost-effectiveness of risk-tailored melanoma screeningKirstie G McLoughlin, Caroline G Watts, Stephen Wade, et al.
The Australasian Journal of Dermatology|February 21, 2022
Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanomaThomas E Pennington, Cathy Yunjia Zhao, Andrew J Colebatch, et al.
Organic & Biomolecular Chemistry|April 10, 2015
Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitorsMaria J Pineda de las Infantas, Sara Torres-Rusillo, Juan Diego Unciti-Broceta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 13, 2023
Contribution of <i>APOE</i> Genetic Variants to DyslipidemiaAna M Bea, Asier Larrea-Sebal, Victoria Marco-Benedi, et al.
Diabetes|June 30, 2022
Fibronectin-Integrin α5 Signaling in Vascular Complications of Type 1 DiabetesMinghao Chen, Rui Hu, Cristina Cavinato, et al.
JAMA Dermatology|March 17, 2021
Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin SurveillancePascale Guitera, Scott W Menzies, Elliot Coates, et al.
Pageof 27